C

CARB-X

30 employees

CARB-X is a biopharmaceutical business enterprise that specializes in biotechnology, antibiotics, vaccines, fast diagnostics.

Investor insights

Sectors invested in

Biotechnology66
Health Care44
Medical32
Pharmaceutical27
Therapeutics19
Medical Device11
Biopharma10
Life Science6
Health Diagnostics4
Microbiology4
Antibiotic Resistance4
antibiotics4
Molecular Diagnostics3
Antibiotic resistance3
antibiotic resistance3
Antibiotics3
Microbiome2
Small molecules2
Tuberculosis2
Nosocomial infections2

Funding rounds participated in

$4.5M sweet spot round size

Most of their 92 investments are in rounds between $2.6M and $7.8M

Investor type

Accelerator

Basic info

Industry

biotechnology research

Sectors

Date founded

2016

Investments made

D

Day Zero Diagnostics, Inc raised $8.2M on October 20, 2022

Investors: CARB-X

A

Avails Medical, Inc. raised $1.7M on September 1, 2022

Investors: CARB-X

C

Clarametyx Biosciences raised $3.9M on April 4, 2022

Investors: CARB-X

V

Vaxcyte raised $3.2M on August 5, 2021

Investors: CARB-X

B

BioVersys AG raised $4.4M on June 1, 2021

Investors: CARB-X

S

SNIPR Biome - A CRISPR Company raised $10M on May 27, 2021

Investors: CARB-X

B

Basilea Pharmaceutica raised $2.7M on May 19, 2021

Investors: CARB-X

U

Undisclosed raised $4.1M on May 18, 2021

Investors: CARB-X

S

SpeeDx Pty Ltd raised $1.8M on May 10, 2021

Investors: CARB-X

G

GenomeKey raised $9.5M on April 27, 2021

Investors: CARB-X

FAQ